Cotización XOMA Royalty - XOMAO

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

25.25

Postura de Compra

25.00

Postura de Venta

25.81

Volume Operado de la Acción

389

25.33 Rango del Día 25.33

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

297.515M

Precio Anterior

25.25

Precio de Apertura

25.33

Hora

25.33

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

Acciones en circulación

11,782,723

Rendimiento del Dividendo

8.29%

Ratio Precio/Utilidad

-7.75

Beneficio por acción (BPA)

-3.47

turnover

4.76M

Beneficio neto

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.xoma.com

Sede

Wilmington, Delaware, USA

Fundado

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMAO. The last closing price for XOMA Royalty was US$25.25. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 0.00 to US$ 0.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$297.51 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.75.

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

XOMAO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de XOMA Royalty?

El precio actual de las acciones de XOMA Royalty es US$ 25.25

¿Cuántas acciones de XOMA Royalty están en circulación?

XOMA Royalty tiene 11,782,723 acciones en circulación

¿Cuál es la capitalización de mercado de XOMA Royalty?

La capitalización de mercado de XOMA Royalty es USD 297.51M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de XOMA Royalty?

XOMA Royalty ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de XOMA Royalty?

El ratio precio/beneficio de XOMA Royalty es -7.75

¿Cuál es el ratio de efectivo a ventas de XOMA Royalty?

El ratio de efectivo a ventas de XOMA Royalty es 66.54

¿Cuál es la moneda de reporte de XOMA Royalty?

XOMA Royalty presenta sus resultados financieros en USD

¿Cuál es el último ingresos anual de XOMA Royalty?

El último ingresos anual de XOMA Royalty es USD 4.76M

¿Cuál es el último beneficio anual de XOMA Royalty?

El último beneficio anual de XOMA Royalty es USD -40.83M

¿Cuál es la dirección registrada de XOMA Royalty?

La dirección registrada de XOMA Royalty es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

¿Cuál es la dirección del sitio web de XOMA Royalty?

La dirección del sitio web de XOMA Royalty es www.xoma.com

¿En qué sector industrial opera XOMA Royalty?

XOMA Royalty opera en el sector PHARMACEUTICAL PREPARATIONS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
EVAXEvaxion Biotech AS	US$ 5.99 (64.56%)	55.41M
ELABPMGC Holdings Inc	US$ 3.0901 (56.07%)	76.48M
PCLAPicoCELA Inc	US$ 4.60 (49.35%)	3.75M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
GODNUGolden Star Acquisition Corporation	US$ 3.11 (-75.82%)	17.51k
GODNGolden Star Acquisition Corporation	US$ 2.93 (-65.67%)	902.76k
NXTTNext Technology Holding Inc	US$ 1.37 (-54.93%)	2.56M
SGLYSingularity Future Technology Ltd	US$ 1.625 (-38.45%)	917.77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90.11 (-38.07%)	8
ACONAclarion Inc	US$ 0.0557 (28.94%)	811.91M
NVNINVNI Group Ltd	US$ 4.38 (193.96%)	366.98M
RIMEAlgorhythm Holdings Inc	US$ 0.0357 (4.69%)	284.97M
GOEVCanoo Inc	US$ 0.475 (43.94%)	282.22M
NVDANVIDIA Corporation	US$ 142.62 (-3.12%)	232.88M